Related Experiment Video

Updated: Jul 10, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Rational design of transition-state analogues as potent enzyme inhibitors with therapeutic applications

Tina L Amyes1, John P Richard

  • 1Department of Chemistry, University at Buffalo, State University of New York, Buffalo, New York 14260-3000, USA.

ACS Chemical Biology
|November 23, 2007
PubMed

Insights

Enzyme reactions show varied bond cleavage at the ribosyl anomeric carbon. This finding aids in designing new inhibitors for 5'-methylthioadenosine nucleosidases, offering therapeutic potential.

Area of Science:

  • Biochemistry
  • Enzymology
  • Computational Chemistry

Background:

  • Enzyme-catalyzed reactions are crucial in biological processes.
  • Ribosyl group transfer reactions are fundamental in nucleic acid metabolism and signaling.
  • Understanding transition states is key to enzyme mechanism elucidation.

Purpose of the Study:

  • To investigate the structural diversity of transition states in enzyme-catalyzed ribosyl transfer reactions.
  • To correlate kinetic isotope effects with transition state geometries.
  • To inform the development of novel therapeutic agents.

Main Methods:

  • Computational evaluation of tritium and heavy atom kinetic isotope effects.
  • Analysis of transition state structures for various enzymatic reactions.
  • Structure-based design of enzyme inhibitors.

Main Results:

  • Significant variation in bond cleavage at the ribosyl anomeric carbon across different enzyme-catalyzed reactions.
  • Detailed characterization of transition state structures.
  • Identification of key structural features influencing reaction mechanisms.

Conclusions:

  • Transition state structures in ribosyl transfer reactions are not uniform.
  • Computational analysis of kinetic isotope effects provides valuable mechanistic insights.
  • The findings facilitate the design of high-affinity transition-state analogue inhibitors for 5 ai-methylthioadenosine nucleosidases, with potential therapeutic applications.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Introduction to Mechanisms of Enzyme Catalysis01:13

Introduction to Mechanisms of Enzyme Catalysis

For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes a mild...